Q1 Earnings Forecast for OVID Issued By William Blair
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Equities research analysts at William Blair issued their Q1 2026 EPS estimates for Ovid Therapeutics in a research note issued to investors on Wednesday, March 12th. William Blair analyst S. Schram forecasts that the company will post earnings of ($0.18) per share for the quarter. The consensus […]
